Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H18O3 |
| Molecular Weight | 186.2481 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)O[C@@]2(C)[C@@H](O)C[C@@H]1C[C@H]2O
InChI
InChIKey=JSNQSLSBBZFGBM-UICFKRDXSA-N
InChI=1S/C10H18O3/c1-9(2)6-4-7(11)10(3,13-9)8(12)5-6/h6-8,11-12H,4-5H2,1-3H3/t6-,7+,8-,10+
| Molecular Formula | C10H18O3 |
| Molecular Weight | 186.2481 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1484159Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12071332 | https://www.ncbi.nlm.nih.gov/pubmed/8372050 | https://www.ncbi.nlm.nih.gov/pubmed/10961725 | https://www.ncbi.nlm.nih.gov/pubmed/3893863
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1484159
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/12071332 | https://www.ncbi.nlm.nih.gov/pubmed/8372050 | https://www.ncbi.nlm.nih.gov/pubmed/10961725 | https://www.ncbi.nlm.nih.gov/pubmed/3893863
Epomediol (trade name Clesidren) is a synthetic terpenoid with choleretic effects that have been used in the symptomatic treatment of itching due to intrahepatic cholestasis of pregnancy. Epomediol is able to restore a normal hepatocyte bile acid uptake when given in vivo simultaneously with ethinyloestradiol but does not influence bile acid transport in cultured hepatocyte
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Intrahepatic cholestasis of pregnancy. | 2007-05-29 |
|
| Effects of epomediol on ethinyloestradiol-induced changes in glutathione homeostasis in the rat. | 2002-03 |
|
| Effect of epomediol on ethinyloestradiol-induced changes in bile acid and cholesterol metabolism in rats. | 2001-08 |
|
| Enhancement of bile acid pool size, synthesis and secretion by epomediol in the rat. | 2000-07 |
|
| Effect of epomediol on taurocholate uptake in hepatocytes isolated from normal rats or rats with ethinyloestradiol-induced cholestasis. | 1993-04-01 |
|
| [Symptomatic effect of epomediol in patients with cholestasis of pregnancy]. | 1992-05 |
|
| Effect of ethinylestradiol and epomediol on bile flow and biliary lipid composition in rat. | 1992-03-17 |
|
| Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity. | 1989-10-15 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1343068
Patients hospitalized due to ICP received epomediol 900 mg/day (n = 7), or 1,200 mg/day (n = 4) orally, during 15 days.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8372050
Hepatocytes were incubated at different times (15-60 sec. and 5-30 min.) in the presence of different concentrations of labeled and unlabeled taurocholate ( 1 : 9) to determine ['H]-taurocholate uptake. The incubation medium was then rapidly removed and the dishes (3 for each experimental group) were immediately washed with cold saline. In fact, no measurable efflux of bile acids from isolated hepatocytes has been proved to exist at 0C. Finally. 1.5 ml NaOH 0.33 N was added to each dish and after 30 min. 0.5 ml and 0.2 ml of the cellular lysate were taken to count radioactivity and protein content respectively.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:33:07 GMT 2025
by
admin
on
Mon Mar 31 22:33:07 GMT 2025
|
| Record UNII |
KFU4XSK3BK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QA05BA05
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
||
|
WHO-ATC |
A05BA05
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000078929
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
KFU4XSK3BK
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
1116159
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
56084-15-2
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
24263
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | RxNorm | ||
|
Epomediol
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
1310101-21-3
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
1033
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
SUB13692MIG
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL3707255
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
DTXSID70971470
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
DB13802
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY | |||
|
C031365
Created by
admin on Mon Mar 31 22:33:07 GMT 2025 , Edited by admin on Mon Mar 31 22:33:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |